Spots Global Cancer Trial Database for Autologous Stem Cell Rescue for Primary Amyloidosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Autologous Stem Cell Rescue for Primary Amyloidosis
Official Title: High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis
Study ID: NCT00186407
Study Description
Brief Summary: To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis.
Detailed Description: To learn about the use of high dose chemotherapy followed by transplantation using peripheral blood stem cells.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford University School of Medicine, Stanford, California, United States
Contact Details
Name: Sally Arai
Affiliation: Stanford University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
